Why the study?
Does intravenous fenoldopam induce natriuresis and alter renal hemodynamics in normal male subjects?
Does intravenous fenoldopam induce natriuresis and alter renal hemodynamics in normal male subjects?
Intravenous fenoldopam causes natriuresis through direct renal tubular action and increases renal plasma flow without changing glomerular filtration rate in normal men.
This is the authors' abstract. We don't add key points for this paper.
The selective dopamine-1 (DA-1) receptor agonist, fenoldopam, was studied during intravenous administration to ten normal male subjects on a diet of 150 mEq sodium and 60 mEq potassium per day to determine the mechanism of dopamine-induced natriuresis. During DA-1 receptor stimulation, urine flow rate and renal plasma flow manifested a biphasic increase. Urine flow rate increased from a control of 13 +/- 1 to 17 +/- 1.2 ml/min and again to a peak of 16 +/- 1. Renal plasma flow increased from 344 +/- 39 to 481 +/- 44 ml/min and then to 497 +/- 38. Sodium excretion (UNaV) and fractional sodium excretion (FENa) demonstrated a sustained increase. UNaV rose from a control of 0.21 +/- 0.03 to 0.32 +/- 0.05 mEq/min. FENa rose from a control of 1.6 +/- 0.1 to 2.7 +/- 0.6%. Fenoldopam did not alter glomerular filtration rate. The association of changes in renal plasma flow and in UNaV and FENa demonstrate in man that DA-1 receptor stimulation causes natriuresis by direct renal tubular action. The renal tubular effect appears to be a major determinant of the degree of natriuresis.
Answers are grounded in this paper and cite their sources.
Supports DA-1 agonism as a probe for renal hemodynamics in humans; leaves open translation to patients with hypertension or heart failure.
No takes yet. Share an insight, caveat, or question.
Carey et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: